GSK to acquire cancer drugmaker Tesaro in $5.1B deal
Note: This section contains information in English only.
Mon, 03 Dec 2018 13:58:05 GMT
Source: Dukascopy Bank SA
GlaxoSmithKline agreed on a deal to acquire the US cancer drugmaker Tesaro for $5.1B, the major biotech investment made by the drug specialist, as it hopes to reform its pharmaceuticals portfolio.
For further information regarding potential cooperation, please call us or make callback request.
To learn more about Dukascopy Bank Binary Options
/ Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Business Introducer and other trading related information, please call us or make callback request.
For further information regarding potential cooperation, please call us or make callback request.